Selective extraocular muscle regression following tocilizumab in active thyroid associated ophthalmopathy: a 3D MRI-based retrospective study.

Nan F, Zhang Y, Ma Y, Yang C, Ma X, An N, Piao S, Zhang X, Yang L, Zheng Y, Cui X, Ma T, Mai Q, Zhuang W, Li Q

DOI: 10.3389/fendo.2026.1930592
Published: 2026
Container: Frontiers in endocrinology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2026.1930592,
  title = {Selective extraocular muscle regression following tocilizumab in active thyroid associated ophthalmopathy: a 3D MRI-based retrospective study.},
  author = {Nan F and Zhang Y and Ma Y and Yang C and Ma X and An N and Piao S and Zhang X and Yang L and Zheng Y and Cui X and Ma T and Mai Q and Zhuang W and Li Q},
  year = {2026},
  journal = {Frontiers in endocrinology},
  doi = {10.3389/fendo.2026.1930592},
  url = {https://doi.org/10.3389/fendo.2026.1930592}
}

RIS

TY  - JOUR
TI  - Selective extraocular muscle regression following tocilizumab in active thyroid associated ophthalmopathy: a 3D MRI-based retrospective study.
AU  - Nan F
AU  - Zhang Y
AU  - Ma Y
AU  - Yang C
AU  - Ma X
AU  - An N
AU  - Piao S
AU  - Zhang X
AU  - Yang L
AU  - Zheng Y
AU  - Cui X
AU  - Ma T
AU  - Mai Q
AU  - Zhuang W
AU  - Li Q
PY  - 2026
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2026.1930592
UR  - https://doi.org/10.3389/fendo.2026.1930592
ER  -

APA

F, N., Y, Z., Y, M., C, Y., X, M., N, A., S, P., X, Z., L, Y., Y, Z., X, C., T, M., Q, M., W, Z., & Q, L. (2026). Selective extraocular muscle regression following tocilizumab in active thyroid associated ophthalmopathy: a 3D MRI-based retrospective study.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1930592

Source records

pubmed · retrieved 2026-09-27T07:49:53.127Z